“…Sub-analysis of primary outcomes in postmenopausal women (age > 55) showed decreased postsurgery LOS (33.4 h vs. 37.4 h; P = 0.0208) and decreased blood loss (35.9 ml vs. 82.7 ml; P < 0.0001) in the BSO group compared to control. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Mortality risk was 4.2 (95% CI 4.1–4.4), prolonged LOS 3.3 (95% CI 3.3–3.4) and readmission 1.8 (95% CI 1.7–1.9) times higher in patients with both factors present compared with patients with neither. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…In-hospital mortality rate (18.7% vs 6.9%; p < 0.001) and mean overall LOS (33.5 vs 18.8 days; p < 0.001) were higher and longer, respectively, in cases versus controls. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…The ESP block and PCA groups both had a significantly shorter average LOS (3.3 and 3.7 days, respectively) than the TE group (4.7 days). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…However, when we categorized all patients into time quartiles (ED-LOS: < 3.3 hr, 3.3–4.5 hr, 4.6–6.1 hr, and > 6.1 hr), patients in the higher time quartiles (e.g., 3.3–4.5 hr) had higher 28-day mortality compared with those in the lowest time quartile (< 3.3 hr) (e.g., adjusted OR for patients in the second time quartile [3.3–4.5 hr] 1.59; 95% CI, 1.03–2.46; p = 0.04). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Se excluyeron las muestras de pacientes pediátricos (<18 años), así como de aquellos sujetos con factores que pudieran afectar a los niveles de 25-(OH)D y/o PTH (e.g. insuficiencia renal, enfermedad hepática, trastornos de la PTH). RESULTADOS: En los 33.601 pacientes (24.028 mujeres y 9.573 hombres), la prevalencia del déficit de 25-(OH)D fue del 48%. …”
Enlace del recurso
Enlace del recurso

“…Patients with major complications had significantly increased CCI scores (53 vs. 6, P < 0.01), reoperations (74 vs. 0%, P < 0.01), and LOS (33 vs. 7, P < 0.01). SMA and SMI were comparable between both groups (126.0 vs. 125.2 cm(2), P = 0.974, and 43.4 vs. 44.3 cm(2)/m(2), P = 0.636, respectively), while SMRA was significantly lower in patients with major complications (33.6 vs. 37.3 HU, P = 0.018). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Primary endpoint was not different (medians (IQR) post-ICU LOS 33(13;90) vs. 33(11;90) days for intervention and control, respectively, median difference − 1(− 3;1) days, p = 0.78). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso